Davis Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Davis Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83	Buy	+1	New	+$80	﹤0.01%	1104

Other funds holding ANIP

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Davis Capital Management's ANIP Position: Q2 2026 in Review

Davis Capital Management opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 1 share worth $83. The stake represents ﹤0.01% of the portfolio and ranks #1104 among its holdings.

39 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Davis Capital Management held 1 share of ANI Pharmaceuticals worth $83 as of Q2 2026.
ANI Pharmaceuticals was a new Davis Capital Management position in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1104 holding.
39 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.